e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Immune mechanisms in the human lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data
Jing Yang (Beijing, China), Jing Yang, Michael Humphries, Shuang Ren, Linda Wang, Abhijit Pethe, Ioannis Kottakis
Source:
International Congress 2015 – Immune mechanisms in the human lung
Session:
Immune mechanisms in the human lung
Session type:
Thematic Poster Session
Number:
4038
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jing Yang (Beijing, China), Jing Yang, Michael Humphries, Shuang Ren, Linda Wang, Abhijit Pethe, Ioannis Kottakis. Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data. Eur Respir J 2015; 46: Suppl. 59, 4038
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Effect of an individualized education program on asthma control and health-related quality of life in adult asthma patients: A prospective study
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016
Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial.
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Factors associated with patient perspective outcomes in a cohort of asthmatics
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Examination of variations in responder rates in COPD clinical trial outcomes
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Identification and validation of asthma phenotypes in Chinese population using cluster analysis
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Source: International Congress 2016 – Asthma management
Year: 2016
The German Severe Asthma Registry: FeNO values correlate with medical therapy, quality of life and smoking
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Education of asthmatic children: Impact on the perception and on the control of the disease and usefulness of an asthma logbook
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Longitudinal relationship between disease specific quality of life and asthma control in children
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Which are the main determinants of quality-of-life in severe asthma?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept